Skip to main content

Table 3 Oxygenation and ventilation variables, respiratory rate (RR), and outcome in the two study groups

From: Could early infusion of fish-oil-based lipid emulsion affect the need for intensive care in moderately diseased COVID-19 patients? A randomized clinical trial

Variables

Group C (n = 30)

Group L (n = 30)

P-value

Need for ventilation and/or oxygenation

No need

16 (53.3%)

24 (80.0%)

0.028*

In need

14 (46.7%)

6 (20.0%)

Respiratory rate (RR)

Admission

14.00

14.00

0.705

2nd day

15.00

14.00

0.087

3rd day

16.00

14.00

0.224

5th day

18.00

15.00

0.005*

7th day

20.00

18.00

0.017*

P/F ratio

Admission

211.97 ± 26.78

206.70 ± 29.52

0.472

2nd day

203.70 ± 30.14

204.07 ± 26.67

0.960

3rd day

190.27 ± 35.40

202.17 ± 27.71

0.152

5th day

182.50 (123.00–215.00)

198.50 (188.00–216.00)

0.044*

7th day

169.50 (100.00–203.00)

197.50 (178.00–215.00)

0.019*

Outcome

Home discharge

3

8

0.055

ICU shift

14

6

Continued treatment inward after a study time frame

13

16

Died

0

0

  1. Data are presented as numbers (percentages)
  2. P/F ratio Partial arterial oxygen tension/faction of inspired oxygen
  3. Group C (standard enteral nutrition) and Group L (fish-oil-based intravenous lipid emulsion)
  4. *P < 0.05 is considered statistically significant